Supplementary Tables S1-S3 from BRAF Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors

Table S1. Nucleotidic sequences of primers and probes used in the qPCR analyses. Table S2. Detailed description of BRAF copy number (CN) and mutant-allele specific quantification results. Table S3. Analysis of the association between BRAF copy number and mutant allele frequency with best response by Fisher''s exact test.